Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstruc...

Josep Darbà, Gabriela Ramírez, Juan L García-Rivero, Sagrario Mayoralas-Alises, José-Francisco Pascual-Lledó, Diego Vargas, Adi Bijedic
  • ClinicoEconomics and Outcomes Research, February 2017, Dove Medical Press
  • DOI: 10.2147/ceor.s125301

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.2147/ceor.s125301

The following have contributed to this page: Sagrario Mayoralas Alises